Literature DB >> 3764701

Liver resection for metastatic colorectal cancer.

S Iwatsuki, C O Esquivel, R D Gordon, T E Starzl.   

Abstract

From 1975 to 1985, 60 patients with isolated hepatic metastases from colorectal cancer were treated by 17 right trisegmentectomies, five left trisegmentectomies, 20 right lobectomies, seven left lobectomies, eight left lateral segmentectomies, and three nonanatomic wedge resections. The 1-month operative mortality rate was 0%. One- to 5-year actuarial survival rates of the 60 patients were 95%, 72%, 53%, 45%, and 45%, respectively. The survival rate after liver resection was the same when solitary lesions were compared with multiple lesions. However, none of the seven patients with four or more lesions survived 3 years. The interval after colorectal resection did not influence the survival rate after liver resection, and survival rates did not differ statistically when synchronous metastases were compared with metachronous tumors. A significant survival advantage of patients with Dukes' B primary lesions was noted when compared with Dukes' C and D lesions. The pattern of tumor recurrence after liver resection appeared to be systemic rather than hepatic. The patients who received systemic chemotherapy before clinical evidence of tumor recurrence after liver resection survived longer than those who did not.

Entities:  

Mesh:

Year:  1986        PMID: 3764701      PMCID: PMC2975979     

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Left hepatic trisegmentectomy.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; P M Waterman; D Van Thiel; H S Diliz; A Dekker; K M Bron
Journal:  Surg Gynecol Obstet       Date:  1982-07

2.  Hepatic resection of metastatic colorectal carcinoma: a ten-year experience.

Authors:  S E Logan; S J Meier; K P Ramming; D L Morton; W P Longmire
Journal:  Arch Surg       Date:  1982-01

3.  Major hepatic resection for metachronous metastases from colon cancer.

Authors:  B Cady; W V McDermott
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

4.  Hepatic resection for isolated metastasis from colorectal carcinoma.

Authors:  N J Petrelli; R N Nambisan; L Herrera; A Mittelman
Journal:  Am J Surg       Date:  1985-02       Impact factor: 2.565

5.  Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy.

Authors:  G Steele; R T Osteen; R E Wilson; D C Brooks; R J Mayer; N Zamcheck; T S Ravikumar
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

6.  Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection.

Authors:  J G Fortner; J S Silva; R B Golbey; E B Cox; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

7.  Resection of hepatic metastases from colorectal cancer.

Authors:  M A Adson; J A van Heerden; M H Adson; J S Wagner; D M Ilstrup
Journal:  Arch Surg       Date:  1984-06

8.  Hepatic resection for metastases of the colon and rectum.

Authors:  J Butler; F F Attiyeh; J M Daly
Journal:  Surg Gynecol Obstet       Date:  1986-02

9.  Right trisegmentectomy for hepatic neoplasms.

Authors:  T E Starzl; L J Koep; R Weil; J R Lilly; C W Putnam; J A Aldrete
Journal:  Surg Gynecol Obstet       Date:  1980-02

10.  Experience with 150 liver resections.

Authors:  S Iwatsuki; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

  10 in total
  40 in total

Review 1.  The surgical treatment of hepatic metastases in colorectal carcinoma.

Authors:  Ulf Peter Neumann; Daniel Seehofer; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2010-05-14       Impact factor: 5.594

Review 2.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

Review 3.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

4.  Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

Authors:  M Lorenz; H H Müller; H Schramm; H J Gassel; H G Rau; K Ridwelski; J Hauss; R Stieger; K W Jauch; W O Bechstein; A Encke
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

5.  Role of computed tomographic arterial portography and intraoperative ultrasound in the evaluation of patients for resectability of hepatic lesions.

Authors:  R C Karl; J Choi; T J Yeatman; R A Clark
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

6.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

7.  Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

Authors:  M Minagawa; M Makuuchi; G Torzilli; T Takayama; S Kawasaki; T Kosuge; J Yamamoto; H Imamura
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

8.  Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases.

Authors:  J P Lodge; B J Ammori; K R Prasad; M C Bellamy
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

9.  Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer.

Authors:  J K Seifert; D L Morris
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

10.  Prediction of surgical resectability in patients with hepatic colorectal metastases.

Authors:  S B Vogel; W E Drane; P R Ros; S R Kerns; K I Bland
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.